Skip to content

Evaluation of using Ropivacaine in orthognathic surgery

Evaluation of using Ropivacaine as a long acting anesthesia on systemic factors, amount of using opioid and bleeding during operation and post-operative pain in orthognathic surgery comparing with lidocaine

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170718035163N1
Enrollment
40
Registered
2019-07-20
Start date
2019-05-22
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cl III jaw deformity. Anomalies of jaw-cranial base relationship

Interventions

Intervention 1: Intervention group: includes group that 2cc Ropivacaine 0/5% (naropin) as preoperative anesthesia at BSSO incision and 4cc at lefort incision before begining orthognathic surgery are u

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The patients who have cl III with discrepancy up to 10 mm.

Exclusion criteria

Exclusion criteria: The patients who have systemic diseases especially kidney disease. The patients who have history of allergy to drugs using in the study

Design outcomes

Primary

MeasureTime frame
Systemic factors including heart rate, mean arterial pressure, breathing, SPo2. Timepoint: Evaluating systemic factors 15, 30, 45, 60, 75, 90, 105, 120 minutes after starting the surgery. Method of measurement: Monitoring device.

Secondary

MeasureTime frame
Evaluating the amounts of pain after surgery. Timepoint: Evaluating pain 2, 6, 12, 18, 24 hours after surgery. Method of measurement: VAS scale.;Amounts of using narcotics during surgery. Timepoint: Measuring narcotic consumption after starting surgery. Method of measurement: Determined by anesthetic team.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMozhgan Kazemian

Mashhad University of Medical Sciences

kazemianmz@mums.ac.ir+98 51 3882 9501

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026